4.8 Article

Serine Protease Inhibition by a Silanediol Peptidomimetic

Journal

ORGANIC LETTERS
Volume 14, Issue 17, Pages 4422-4425

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/ol301933n

Keywords

-

Funding

  1. National Institutes of Health [R01 GM076471]

Ask authors/readers for more resources

Silanediol peptidomimetics are demonstrated to inhibit a serine protease. Asymmetric synthesis of the inhibitor was accomplished using Brown hydroboration and CBS reduction of an acylsilane intermediate. The silanediol product was found to inhibit the serine protease chymotrypsin with a K-i of 107 nM. Inhibition of the enzyme may involve exchange of a silane hydroxyl with the active site serine nucleophile, contrasting with previous silanediol protease inhibitors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available